Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation

References

• Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: Part one-photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 2004; 1: 279–293
   PubMed Web of Science ®Google Scholar
• Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003; 3: 380–387
   PubMed Web of Science ®Google Scholar
• Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889–905
   PubMed Web of Science ®Google Scholar
• Fang J, Sawa T, Akaike T, Akuta T, Sahoo SK, Khaled G, Hamada A, Maeda H. In vivo antitumor activity of pegylated zinc protoporphyrin: Targeted inhibition of heme oxygenase in solid tumor. Cancer Res 2003; 63: 3567–3574
   PubMed Web of Science ®Google Scholar
• Fang J, Sawa T, Akaike T, Greish K, Maeda H. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. Int J Cancer 2004; 109: 1–8
   PubMed Web of Science ®Google Scholar
• Greish K, Fang J, Inutsuka T, Nagamitsu A, Maeda H. Macromolecular therapeutics: Advantages and prospects with special emphasis on solid tumour targeting. Clin Pharmacokinet 2003; 42: 1089–1105
   PubMed Web of Science ®Google Scholar
• Greish K, Sawa T, Fang J, Akaike T, Maeda H. SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours. J Control Release 2004; 97: 219–230
   PubMed Web of Science ®Google Scholar
• Greish K, Nagamitsu A, Fang J, Maeda H. Copoly(styrene-maleic acid)-pirarubicin micelles: High tumor-targeting efficiency with little toxicity. Bioconjug Chem 2005; 16: 230–236
   PubMed Web of Science ®Google Scholar
• Harada A, Kataoka K. Chain length recognition: Core-shell supramolecular assembly from oppositely charged block copolymers. Science 1999; 283: 65–67
   PubMed Web of Science ®Google Scholar
• Hasegawa Y, Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Amino N. Decreased expression of catalase mRNA in thyroid anaplastic carcinoma. Jpn J Clin Oncol 2003; 33: 6–9
   PubMed Web of Science ®Google Scholar
• Ideta R, Tasaka F, Jang WD, Nishiyama N, Zhang GD, Harada A, Yanagi Y, Tamaki Y, Aida T, Kataoka K. Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer. Nano Lett 2005; 5: 2426–2431
   PubMed Web of Science ®Google Scholar
• Iyer AK, Greish K, Fang J, Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 2006; 11: 812–818
   PubMed Web of Science ®Google Scholar
• Iyer AK, Greish K, Fang J, Murakami R, Maeda H. High-loading nanosized micelles of copoly(styrene-maleic acid)-zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor. Biomaterials 2007; 10: 1871–1881
   Google Scholar
• Kondo R, Gleixner KV, Mayerhofer M, Vales A, Gruze A, Samorapoompichit P, Greish K, Krauth MT, Aichberger KJ, Pickl WF, Esterbauer H, Sillaber C, Maeda H, Valent P. Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells. Blood 2007, (In press)
   Web of Science ®Google Scholar
• Lion Y, Delmella M, Van De Vorst A. New method of detecting singlet oxygen production. Nature 1976; 263: 442–443
   PubMed Web of Science ®Google Scholar
• Liu J, Ohta S, Sonoda A, Yamada M, Yamamoto M, Nitta N, Murata K, Tabata Y. Preparation of PEG-conjugated fullerene containing Gd3+ ions for photodynamic therapy. J Control Release 2007; 117: 104–110
   PubMed Web of Science ®Google Scholar
• Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989; 6: 193–210
   PubMed Web of Science ®Google Scholar
• Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2000; 41: 189–207
   Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000; 65: 271–284
   PubMed Web of Science ®Google Scholar
• Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 2001; 74: 47–61
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46: 6387–6392
   PubMed Web of Science ®Google Scholar
• Mayerhofer M, Florian S, Krauth MT, Aichberger KJ, Bilban M, Marculescu R, Printz D, Fritsch G, Wagner O, Selzer E, Sperr WR, Valent P, Sillaber C. Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res 2004; 64: 3148–3154
   PubMed Web of Science ®Google Scholar
• McBride G. Studies expand potential uses of photodynamic therapy. J Natl Cancer Inst 2002; 94: 1740–1742
   PubMed Web of Science ®Google Scholar
• Moan J, Wold E. Detection of singlet oxygen production by ESR. Nature 1979; 279: 450–451
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63
   PubMed Web of Science ®Google Scholar
• Nishide H, Mihayashi K, Tsuchida E. Dissociation of aggregated ferroheme complexes and protoporphyrin IX by water-soluble polymers. Biochim Biophys Acta 1977; 498: 208–214
   PubMed Web of Science ®Google Scholar
• Nowis D, Legat M, Grzela T, Niderla J, Wilczek E, Wilczynski GM, Glodkowska E, Mrowka P, Issat T, Dulak J, Jozkowicz A, Was H, Adamek M, Wrzosek A, Nazarewski S, Makowski M, Stoklosa T, Jakobisiak M, Golab J. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene 2006; 25: 3365–3374
   PubMed Web of Science ®Google Scholar
• Noguchi Y, Wu J, Duncan R, Strohalm J, Ulbrich K, Akaike T, Maeda H. Early phase tumor accumulation of macromolecules: A great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res 1998; 89: 307–314
   PubMedGoogle Scholar
• Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 2003; 55: 403–419
   PubMed Web of Science ®Google Scholar
• Regehly M, Greish K, Rancan F, Maeda H, Böhm F, Röder B. Water-soluble polymer conjugates of ZnPP for photodynamic tumor therapy. Bioconjug Chem 2007; 18: 494–499
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Sawa T, Fang J, Tanaka S, Miyamoto Y, Akaike T, Maeda H. Pegylated zinc protoporphyrin: A water-soluble heme oxygenase inhibitor with tumor-targeting capacity. Bioconjug Chem 2002; 13: 1031–1038
   PubMed Web of Science ®Google Scholar
• Sato K, Ito K, Kohara H, Yamaguchi Y, Adachi K, Endo H. Negative regulation of catalase gene expression in hepatoma cells. Mol Cell Biol 1992; 12: 2525–2533
   PubMed Web of Science ®Google Scholar
• Schiwon K, Brauer HD, Gerlach B, Muller CM, Montforts FP. Potential photosensitizers for photodynamic therapy. IV. Photophysical and photochemical properties of azaporphyrin and azachlorin derivatives. J Photochem Photobiol B 1994; 23: 239–243
   PubMed Web of Science ®Google Scholar
• Sharman WM, Allen CM, van Lier JE. Role of activated oxygen species in photodynamic therapy. Methods Enzymol 2000; 319: 376–400
   PubMed Web of Science ®Google Scholar
• Sortino S, Mazzaglia A, Monsu Scolaro L, Marino Merlo F, Valveri V, Sciortino MT. Nanoparticles of cationic amphiphilic cyclodextrins entangling anionic porphyrins as carrier–sensitizer system in photodynamic cancer therapy. Biomaterials 2006; 27: 4256–4265
   PubMed Web of Science ®Google Scholar
• Tabata Y, Murakami Y, Ikada Y. Photodynamic effect of polyethylene glycol-modified fullerene on tumor. Jpn J Cancer Res 1997; 88: 1108–1116
   PubMedGoogle Scholar
• Takeshita K, Olea-Azar CA, Mizuno M, Ozawa T. Singlet oxygen-dependent hydroxyl radical formation during uroporphyrin-mediated photosensitization in the presence of NADPH. Antioxid Redox Signal 2000; 2: 355–362
   PubMed Web of Science ®Google Scholar
• Tang PM, Chan JY, Au SW, Kong SK, Tsui SK, Waye MM, Mak TC, Fong WP, Fung KP. Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma. Cancer Biol Ther 2006; 5: 1111–1116
   PubMed Web of Science ®Google Scholar
• van Nostrum CF. Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv Drug Deliv Rev 2004; 56: 9–16
   PubMed Web of Science ®Google Scholar
• Veronese FM, Schiavon O, Pasut G, Mendichi R, Andersson L, Tsirk A, Ford J, Wu G, Kneller S, Davies J, Duncan R. PEG-doxorubicin conjugates: Influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution and antitumor activity. Bioconjug Chem 2005; 16: 775–784
   PubMed Web of Science ®Google Scholar
• Vrouenraets MB, Visser GW, Snow GB, van Dongen GA. Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res 2003; 23: 505–522
   PubMed Web of Science ®Google Scholar
• Wiehe A, Stollberg H, Runge S, Paul A, Senge MO, RÖder B. PDT-related photophysical properties of conformationally distorted palladium(II) porphyrins. J Porphyrins Phthalocyanines 2001; 5: 853–860
   Web of Science ®Google Scholar
• Wilson BC. Photodynamic therapy for cancer: Principles. Can J Gastroenterol 2002; 16: 393–396
   PubMed Web of Science ®Google Scholar